Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1964 |
No grāmatas satura
1.–5. rezultāts no 100.
14. lappuse
... drug is des- ignated shall be clearly distinguishing and differentiating from any name rec- ognized in an official compendium unless such drug complies in identity with the ... drug which is in such unit 14 $ 1.100 Title 21 - Food and Drugs.
... drug is des- ignated shall be clearly distinguishing and differentiating from any name rec- ognized in an official compendium unless such drug complies in identity with the ... drug which is in such unit 14 $ 1.100 Title 21 - Food and Drugs.
15. lappuse
... drug which is in such unit form shall be in terms of the nu- merical count of such units , supple- mented , when necessary to give accurate information as to the quantity of such drug in the package , by such statement ( in such terms ...
... drug which is in such unit form shall be in terms of the nu- merical count of such units , supple- mented , when necessary to give accurate information as to the quantity of such drug in the package , by such statement ( in such terms ...
17. lappuse
... drug , whether added to the formulation as a single substance or in admixture with other substances . ( c ) The labeling of a drug may be misleading by reason ( among other rea- sons ) of : ( 1 ) The order in which the names of the ...
... drug , whether added to the formulation as a single substance or in admixture with other substances . ( c ) The labeling of a drug may be misleading by reason ( among other rea- sons ) of : ( 1 ) The order in which the names of the ...
18. lappuse
... drug containing two or more active in- gredients , if the label bears a proprietary name or designation for such mixture and there is no established name corre- sponding to such proprietary name or designation , the quantitative ...
... drug containing two or more active in- gredients , if the label bears a proprietary name or designation for such mixture and there is no established name corre- sponding to such proprietary name or designation , the quantitative ...
20. lappuse
... drug only for those purposes for which the article is generally recognized as safe and effective by medical experts ... drug is effective for such purposes . The advertisement shall present infor- mation concerning those side effects and ...
... drug only for those purposes for which the article is generally recognized as safe and effective by medical experts ... drug is effective for such purposes . The advertisement shall present infor- mation concerning those side effects and ...
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
0.2 percent 52 Stat acetate acid added amended Amprolium antibiotic assure safe bacitracin bear the statement blank being filled calcium cheese chickens chloride Chlortetracycline colby cheese color additive combination container cream curd D&C Red definition and standard dried dye as determined exceed exemption Ext D&C extract Federal Food feed flavoring flour food additive food packaging fruit glucose sirup grams gredients Hygromycin ingre ingredients specified juice July June 30 label shall bear label statement less matter at 135 ment methyl methylene milligrams million mixture Nystatin optional ingredients orange oxide Oxytetracycline oysters packing percent by weight petition prepared principal ingredient procaine penicillin process cheese Pure dye quantity regulations salt shrimp sieve sirup skim milk sodium solids specified in paragraph spice standard of identity statement of optional streptomycin subparagraph Subpart substance sugar sulfate tion titanium trichloride tolerances for residues tylosin zinc bacitracin
Populāri fragmenti
421. lappuse - As used in this subsection and subsection (e), the term "substantial evidence" means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be, concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended,...
10. lappuse - If the testimony of a witness refers to a statute, or to a report, document or transcript, the presiding officer, after inquiry relating to the identification of such statute, report, document or transcript, shall determine whether the same shall be produced at the hearing and physically be made a part of the evidence as an exhibit, or whether it shall be incorporated into the evidence by reference. If relevant and material matter offered in evidence is embraced in a report...
434. lappuse - Caution — If pain persists for more than 10 days, or redness is present, or in conditions affecting children under 12 years of age consult a physician Immediately.
43. lappuse - Commissioner under the provisions of section 409 (b) of the act shall be submitted In triplicate. If any part of the material submitted is in a foreign language, it shall be accompanied by an accurate and complete English translation. The petition shall state petitioner's...
4. lappuse - ... is below the quantity stated, and no unreasonable shortage in any package shall be permitted, even though overages in other packages in the same shipment or delivery compensate for such shortage.